Who We Are

Our technology is developed by physicians for physicians. Inspiration for Cycle Clarity came to our founder, Dr. John Schnorr, when he realized that the inefficiency, inaccuracy and lack of standardization of ovarian follicular ultrasound measurements could be solved with the latest advances in artificial intelligence image analysis benefiting both the patients and clinics. Early proof of concept trials demonstrated that a trained recurrent neural network could in fact identify follicles within an ovarian ultrasound. The Cycle Clarity team then began the painstaking process of annotating 19,776 ovarian ultrasound images containing 91,782 ovarian follicles. Each of the annotated follicles were reviewed for accuracy and approved by a board certified reproductive endocrinologist before AI training. This training process resulted in the development and FDA clearance of Follicle Clarity after 5 clinical trials.

And so Follicle Clarity was born and formed the core technology that powers MyCycleClarity platform’s predictive analytics. The wealth of resulting follicular data from each individual patient combined with the same results of all of the other patients in the center now empowers the clinic with data that has never been available to your team before. Imagine the benefits of providing your physicians with a complete understanding of a patients follicular status combined with a real time understanding of embryology workload to enhance trigger and staffing decisions. This is one of the many examples of the benefits of the MyCycleClarity data analysis and predictive algorithms.

Our team of physicians, embryologists, computer engineers, data scientists, biomedical engineers, ultrasonographers, and biostatisticians are committed to helping fertility centers around the world to support improved fertility outcomes together.